Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the...
Annals of Hematology - Carfilzomib, a next-generation proteasome inhibitor, improves outcomes in patients with multiple myeloma (MM); however, a proportion of those treated develop renal failure...
link.springer.com